Cargando…
Clinical application of MR-Linac in tumor radiotherapy: a systematic review
Recent years have seen both a fresh knowledge of cancer and impressive advancements in its treatment. However, the clinical treatment paradigm of cancer is still difficult to implement in the twenty-first century due to the rise in its prevalence. Radiotherapy (RT) is a crucial component of cancer t...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015924/ https://www.ncbi.nlm.nih.gov/pubmed/36918884 http://dx.doi.org/10.1186/s13014-023-02221-8 |
_version_ | 1784907302165282816 |
---|---|
author | Liu, Xin Li, Zhenjiang Yin, Yong |
author_facet | Liu, Xin Li, Zhenjiang Yin, Yong |
author_sort | Liu, Xin |
collection | PubMed |
description | Recent years have seen both a fresh knowledge of cancer and impressive advancements in its treatment. However, the clinical treatment paradigm of cancer is still difficult to implement in the twenty-first century due to the rise in its prevalence. Radiotherapy (RT) is a crucial component of cancer treatment that is helpful for almost all cancer types. The accuracy of RT dosage delivery is increasing as a result of the quick development of computer and imaging technology. The use of image-guided radiation (IGRT) has improved cancer outcomes and decreased toxicity. Online adaptive radiotherapy will be made possible by magnetic resonance imaging-guided radiotherapy (MRgRT) using a magnetic resonance linear accelerator (MR-Linac), which will enhance the visibility of malignancies. This review's objectives are to examine the benefits of MR-Linac as a treatment approach from the perspective of various cancer patients' prognoses and to suggest prospective development areas for additional study. |
format | Online Article Text |
id | pubmed-10015924 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-100159242023-03-16 Clinical application of MR-Linac in tumor radiotherapy: a systematic review Liu, Xin Li, Zhenjiang Yin, Yong Radiat Oncol Review Recent years have seen both a fresh knowledge of cancer and impressive advancements in its treatment. However, the clinical treatment paradigm of cancer is still difficult to implement in the twenty-first century due to the rise in its prevalence. Radiotherapy (RT) is a crucial component of cancer treatment that is helpful for almost all cancer types. The accuracy of RT dosage delivery is increasing as a result of the quick development of computer and imaging technology. The use of image-guided radiation (IGRT) has improved cancer outcomes and decreased toxicity. Online adaptive radiotherapy will be made possible by magnetic resonance imaging-guided radiotherapy (MRgRT) using a magnetic resonance linear accelerator (MR-Linac), which will enhance the visibility of malignancies. This review's objectives are to examine the benefits of MR-Linac as a treatment approach from the perspective of various cancer patients' prognoses and to suggest prospective development areas for additional study. BioMed Central 2023-03-14 /pmc/articles/PMC10015924/ /pubmed/36918884 http://dx.doi.org/10.1186/s13014-023-02221-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Liu, Xin Li, Zhenjiang Yin, Yong Clinical application of MR-Linac in tumor radiotherapy: a systematic review |
title | Clinical application of MR-Linac in tumor radiotherapy: a systematic review |
title_full | Clinical application of MR-Linac in tumor radiotherapy: a systematic review |
title_fullStr | Clinical application of MR-Linac in tumor radiotherapy: a systematic review |
title_full_unstemmed | Clinical application of MR-Linac in tumor radiotherapy: a systematic review |
title_short | Clinical application of MR-Linac in tumor radiotherapy: a systematic review |
title_sort | clinical application of mr-linac in tumor radiotherapy: a systematic review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015924/ https://www.ncbi.nlm.nih.gov/pubmed/36918884 http://dx.doi.org/10.1186/s13014-023-02221-8 |
work_keys_str_mv | AT liuxin clinicalapplicationofmrlinacintumorradiotherapyasystematicreview AT lizhenjiang clinicalapplicationofmrlinacintumorradiotherapyasystematicreview AT yinyong clinicalapplicationofmrlinacintumorradiotherapyasystematicreview |